[1] Asrani SK, Devarbhavi H, Eaton J, et al. Burden of liver diseases in the world[J]. J Hepatol, 2019, 70(1): 151-171.
[2] Cross-Najafi AA, Lopez K, Isidan A, et al. Current Barriers to Clinical Liver Xenotransplantation[J]. Front Immunol, 2022, 13: 827535.
[3] Zhou Q, Li T, Wang K, et al. Current status of xenotransplantation research and the strategies for preventing xenograft rejection[J]. Front Immunol, 2022, 13: 928173.
[4] Mao H, Li J, Liao G, et al. The prevention strategies of swine viruses related to xenotransplantation[J]. Virol J, 2023, 20(1): 121.
[5] Shah JA, Patel MS, Elias N, et al. Prolonged Survival Following Pig-to-Primate Liver Xenotransplantation Utilizing Exogenous Coagulation Factors and Costimulation Blockade[J]. Am J Transplant, 2017, 17(8): 2178-2185.
[6] Zhang X, Li X, Yang Z, et al. A review of pig liver xenotransplantation: Current problems and recent progress[J]. Xenotransplantation, 2019, 26(3): e12497.
[7] Wells KD, Prather RS. Genome-editing technologies to improve research, reproduction, and production in pigs[J]. Mol Reprod Dev, 2017, 84(9): 1012-1017.
[8] Ryu J, Prather RS, Lee K. Use of gene-editing technology to introduce targeted modifications in pigs[J]. J Anim Sci Biotechnol, 2018, 9: 5.
[9] Raza SHA, Hassanin AA, Pant SD, et al. Potentials, prospects and applications of genome editing technologies in livestock production[J]. Saudi J Biol Sci, 2022, 29(4): 1928-1935.
[10] Kuwaki K, Tseng YL, Dor FJ, et al. Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors: initial experience[J]. Nat Med, 2005, 11(1): 29-31.
[11] Yang H, Wu Z. Genome Editing of Pigs for Agriculture and Biomedicine[J]. Front Genet, 2018, 9: 360.
[12] Niu D, Wei HJ, Lin L, et al. Inactivation of porcine endogenous retrovirus in pigs using CRISPR-Cas9[J]. Science, 2017, 357(6357): 1303-1307.
[13] Yue Y, Xu W, Kan Y, et al. Extensive germline genome engineering in pigs[J]. Nat Biomed Eng, 2021, 5(2): 134-143.
[14] Wei J, Zhang W, Li J, et al. Application of the transgenic pig model in biomedical research: A review[J]. Front Cell Dev Biol, 2022, 10: 1031812.
[15] Ramirez P, Chavez R, Majado M, et al. Life-supporting human complement regulator decay accelerating factor transgenic pig liver xenograft maintains the metabolic function and coagulation in the nonhuman primate for up to 8 days[J]. Transplantation, 2000, 70(7): 989-998.
[16] Ramírez P, Montoya MJ, Ríos A, et al. Prevention of hyperacute rejection in a model of orthotopic liver xenotransplantation from pig to baboon using polytransgenic pig livers (CD55, CD59, and H-transferase)[J]. Transplant Proc, 2005, 37(9): 4103-4106.
[17] Ekser B, Echeverri GJ, Hassett AC, et al. Hepatic function after genetically engineered pig liver transplantation in baboons[J]. Transplantation, 2010, 90(5): 483-493.
[18] Kim K, Schuetz C, Elias N, et al. Up to 9-day survival and control of thrombocytopenia following alpha1,3-galactosyl transferase knockout swine liver xenotransplantation in baboons[J]. Xenotransplantation, 2012, 19(4): 256-264.
[19] Shah JA, Navarro-Alvarez N, Defazio M, et al. A Bridge to Somewhere: 25-day Survival After Pig-to-Baboon Liver Xenotransplantation[J]. Ann Surg, 2016, 263(6): 1069-1071. |
